Preventive Angioplasty in Acute Myocardial Infarction - PRAMI


Current guidelines list a Class III indication for nonculprit vessel percutaneous coronary intervention (PCI) in the setting of primary PCI (PPCI) during ST-segment elevation myocardial infarction (STEMI). However, this is based mostly on data from observational studies. The current trial sought to compare outcomes between nonculprit vessel PCI in addition to PCI of the infarct-related artery (IRA) versus PPCI of the IRA alone in patients with STEMI who had multiple stenoses.